StockData
Pulmonx Corp logo

Pulmonx Corp (LUNG) stock

LUNGNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 7/3044% below fair value
$2.73−0.06 (-2.32%)

Close on Nov 17, 2026Market cap $117.46MP/E –Yield –

Pulmonx market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Pulmonx's market cap was $127.99M on Nov 11, 2026, against $66.82M a year earlier. Over the last 5 years it ranged from $53.34M to $1.18B, with a median of $293.11M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$127.99M+40.4%
2025Dec 31, 2025$91.15M-66.0%
2024Dec 31, 2024$268.12M-45.1%
2023Dec 29, 2023$488.34M+54.9%
2022Dec 30, 2022$315.35M-73.3%
2021Dec 31, 2021$1.18B+350.0%
2020Dec 31, 2020$262.40M–

More Pulmonx figures

See a number that looks wrong?